Cargando…

Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis

Empagliflozin is a sodium glucose cotransporter-2 inhibitor that inhibits renal glucose reabsorption through an insulin-independent mechanism. This class of drugs is used in the management of type 2 diabetes. A 49-year-old female with type 2 diabetes treated with empagliflozin presented to the emerg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ray, Gretchen M., Rodriguez, Chelsea, Schulman, Samantha M., Sarangarm, Preeyaporn, Bardack, Michelle, Bouchonville, Matthew F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497210/ https://www.ncbi.nlm.nih.gov/pubmed/31061971 http://dx.doi.org/10.5811/cpcem.2019.2.41795

Ejemplares similares

Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Albugami, Muneerah M., et al.
Publicado: (2020)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2020)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2022)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Empagliflozin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus
por: Chauhan, Sukhjinder, et al.
Publicado: (2023)

Empagliflozin: Euglycemic and hyperglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Empagliflozin: Euglycaemic diabetic ketoacidosis: 2 case reports
Publicado: (2021)

Empagliflozin/linagliptin: Euglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports
por: Altowayan, Waleed M.
Publicado: (2022)

SAT439 Euglycemic Diabetic Ketoacidosis When Combining Empagliflozin With Cocaine
por: Squicimari-de Cardenas, Fabio Alejandro, et al.
Publicado: (2023)

SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019)

SARS-CoV-2 Unmasks Type 1 Diabetes Mellitus With an Episode of Diabetic Ketoacidosis
por: Halioti, Asimenia, et al.
Publicado: (2022)

The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin
por: Candelario, Nellowe, et al.
Publicado: (2016)

Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin
por: Sexe, Jordan, et al.
Publicado: (2020)

Empagliflozin: Euglycaemic diabetic ketoacidosis, masking of hyperglycaemia and hyperglycosuria: case report
Publicado: (2022)

ODP192 Empagliflozin associated Euglycemic Diabetic Ketoacidosis and the Terrible Triad
por: Nievera, Karl Homer, et al.
Publicado: (2022)

Postop Complication With Euglycemic Diabetic Ketoacidosis in a Patient Receiving Empagliflozin
por: Fustiga, João, et al.
Publicado: (2022)

Acute post-operative diabetic ketoacidosis: Atypical harbinger unmasking latent diabetes mellitus
por: Haldar, Rudrashish, et al.
Publicado: (2016)

A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
por: Fernandez Felix, Daniel A, et al.
Publicado: (2022)

THU365 Diabetic Ketoacidosis Unmasking Acute Pancreatitis With A Hidden Surprise
por: Arya, Yajur, et al.
Publicado: (2023)

Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit
por: Bteich, Fernand, et al.
Publicado: (2019)

Empagliflozin/insulin/sodium bicarbonate: Euglycaemic diabetic ketoacidosis and lack of efficacy: case report
Publicado: (2022)

Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis
por: Calçada, Marta Brandão, et al.
Publicado: (2021)

Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient
por: Rathore, Azeem, et al.
Publicado: (2023)

ODP649 COVID-19 Induced Diabetic Ketoacidosis Which Unmasked Latent Autoimmune Diabetes In Adult
por: Alqaisi, Sura, et al.
Publicado: (2022)

Empagliflozin in type 1 diabetes
por: Mathieu, Chantal, et al.
Publicado: (2019)

Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review
por: Sampani, Erasmia, et al.
Publicado: (2020)

Diabetic Ketoacidosis Unmasking a Diagnosis of Glucose-6-Phosphate Dehydrogenase Deficiency: A Case Report and Literature Review
por: Ansari, Umair, et al.
Publicado: (2022)

Detection of Euglycemic Diabetic Ketoacidosis During Thoracic Surgery 75 Hours After Empagliflozin Discontinuation
por: Nishida, Ai, et al.
Publicado: (2022)

Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report
por: Kitahara, Chie, et al.
Publicado: (2020)

Prevention of diabetic ketoacidosis at diagnosis of type 1 diabetes: Are certified athletic trainers an untapped resource?
por: Bogale, Kaleb T., et al.
Publicado: (2020)

Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report
por: Vadasz, Brian, et al.
Publicado: (2021)

Steroid-Induced Diabetes: Is It Just Unmasking of Type 2 Diabetes?
por: Simmons, Lisa R., et al.
Publicado: (2012)

Increase in Prevalence of Diabetic Ketoacidosis at Diagnosis Among Youth With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study
por: Jensen, Elizabeth T., et al.
Publicado: (2021)

Diabetic ketoacidosis as the onset of type 1 diabetes in children
por: Lombardo, Fortunato, et al.
Publicado: (2018)

Euglycemic diabetic ketoacidosis: A missed diagnosis
por: Nasa, Prashant, et al.
Publicado: (2021)

The diabetic ketoacidosis
por: Cardella, Francesca
Publicado: (2014)

Empagliflozin in the treatment of type 2 diabetes: evidence to date
por: Shubrook, Jay H, et al.
Publicado: (2015)

Myopathy secondary to empagliflozin therapy in type 2 diabetes
por: Gao, Frank, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2f2n9adajdu0e0hmlk44sm25nl